1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Mats Remberger: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT Decidua Stroma Cells (DSC), Best available Treatment (BAT) - GVHD, Acute | Phase 2 | Terminated | Mats Remberger | 12 | 2021-12-01 | 2026-05-06 |
Eosinophil Cationic Protein (1) · Etanercept (1) · Everolimus (1) · Infliximab (1) · Sirolimus (1) · ruxolitinib (1) · vedolizumab (1)
Denmark (1) · Norway (1) · Sweden (1)
2019 (1)